Dr. Lenz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1441 Eastlake Ave.
Topping Tower Suite 3456
Los Angeles, CA 90033Phone+1 323-865-3967Fax+1 323-865-0061- Is this information wrong?
Education & Training
- Johannes Gutenberg University of Mainz Faculty of MedicineClass of 1985
Certifications & Licensure
- CA State Medical License 1997 - 2025
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Outstanding Investigator Award Western Society of Clinical Investigation (WSCI), 2016
- Lifetime Achievement Award The WunderGlo Foundation, 2015
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Join now to see all
Clinical Trials
- Simultaneous Care: Linking Palliation to Clinical Trials Start of enrollment: 2002 Feb 01
- Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2011 Jan 18
- Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma Start of enrollment: 2013 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes.Zhishan Chen, Xingyi Guo, Ran Tao, Jeroen R Huyghe, Philip J Law, Ceres Fernandez-Rozadilla, Jie Ping, Guochong Jia, Jirong Long, Chao Li, Quanhu Shen, Yuhan Xie, Mari...> ;Nature Communications. 2024 Apr 26
- Evaluation of markers of immunity in different metastatic immune microenvironments suggests more suppression within breast to liver metastases in breast cancer.Robert Hsu, Batul Al-Zubeidy, Daniel Flores, Ari Nazarian, Aaron Baugh, Edgar Gonzalez, Sofi Castanon, Joanne Xiu, Irene Kang, Darcy Spicer, Heinz Josef Lenz, Lily Dar...> ;Breast Cancer Research and Treatment. 2024 Apr 20
- q-Diffusion leverages the full dimensionality of gene coexpression in single-cell transcriptomics.Myrl G Marmarelis, Russell Littman, Francesca Battaglin, Donna Niedzwiecki, Jose-Luis Ambite, Aram Galstyan, Greg Ver Steeg, Alan Venook, Heinz-Josef Lenz> ;Communications Biology. 2024 Apr 2
- Join now to see all
Journal Articles
- Primary Tumor Sidedness as Prognostic and Predictive Biomarker in Metastatic Colorectal Cancer: Further Validation of a Potentially Practice-Changing VariableLenz H-J, JAMA Oncol, 1/10/2016
- ResponseCremolini C, Loupakis F, Lenz HJ, J Natl Cancer Inst, 1/1/2015
- S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinomaEl-Khoueiry AB, Rankin C, Siegel AB, Iqbal S, Gong IY, Micetich KC, Kayaleh OR, Lenz HJ, Blanke CD, Br J Cancer, 1/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Molecular characterization of intestinal (IS) and diffuse subtypes (DS) of gastric adenocarcinomas.Salem ME, Xiu J, Puccini A, Philip PA, Goldberg RM, Hwang JJ, Kc B, Korn WM, hields AF, Lenz H-J, John Marshall J, J Clin Oncol, 2018 Gastrointestinal Cancers Symposium, San Francisco, CA, 1/18/2018
- A first-in-human phase I study of sEphB4-HSA (sEphB4) with expansion in hepatocellular (HCC) and cholangiocarcinoma (CCA).Thomas JS, Lenz H-J, Iqbal S, Tsao-Wei DD, Barzi A, Duddalwar V, Cole S, Rehman R, Menendez X, Krasnoperov V, Liu R, Feng Q, Gill PS, El-Khoueiry AB, J Clin Oncol, 2018 Gastrointestinal Cancers Symposium, San Francisco, CA, 1/18/2018
- Nivolumab + ipilimumab combination in patients with DNA mismatch repair-deficient/microsatellite instability-high (dMMR/MSI-H) metastatic colorectal cancer (mCRC): Fir...Andre T, Lonardi S, Wong M, Lenz H-J, Gelsomino F, Aglietta M, Morse M, Van Cutsem E, McDermott RS, Hill AG, Sawyer MB, Hendlisz A, Neyns B, Svrcek M, Moss RA, Ledeine..., J Clin Oncol, 2018 Gastrointestinal Cancers Symposium, San Francisco, CA, 1/18/2018
- Join now to see all
Lectures
- Nivolumab plus low-dose ipilimumab as first-line therapy in microsatellite instability-high/DNA mismatch repair deficient metastatic colorectal cancer: Clinical update.ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
- A phase Ib/II study of onvansertib (PCM-075) in combination with FOLFIRI and bevacizumab for second-line treatment of metastatic colorectal cancer (mCRC) in patients w...ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
- Nivolumab (NIVO) + low-dose ipilimumab (IPI) as first-line (1L) therapy in microsatellite instability-high/DNA mismatch repair deficient (MSI-H/dMMR) metastatic colore...2019 ASCO Annual Meeting - 6/1/2019
- Join now to see all
Other
- Metastatic Colorectal Cancer: Results of The Mavericc Study.Lenz HJ, The ASCO Post
1/26/2016 - Nintedanib Externale expert filming session with the subject colorectal cancer.Lenz HJ, 2016 Gastrointestinal Cancers Symposium (Boehringer Ingelheim International gmBh)
1/23/2016 - Module 1: Selection and Sequencing of Therapy for Patients with Newly Diagnosed Metastatic Colorectal Cancer (mCRC).Lenz HJ, REAL-LIFE DECISIONS, Clinical Investigators Provide Their Perspectives on Actual Patients with Metas
San Francisco, CA - 1/21/2016 - Join now to see all
Hospital Affiliations
- Keck Hospital of USCLos Angeles, California
- USC Norris Comprehensive Cancer CenterLos Angeles, California
- Los Angeles General Medical CenterLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: